In late May, the annual meeting of the National Pharmacopeia Authorities (NPA) of the European Pharmacopoeia took place in London. According to the EDQM press release, following the event, the main topics discussed were: ● the implementation strategy for the future ICH Q3D guideline on elemental impurities ● current quality topics that have a potential impact on the Ph. Eur., ● collaboration between pharmacopoeias and quality assessors, official medicines control laboratories and GMP inspectors, ● and the current situation of national pharmacopoeias in member states and sharing best practices. It was noted that most of the participating NPAs had discontinued their national pharmacopoeia and were fully focused on contributing to the Ph. Eur.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
